| Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution JC Stanford, C Young, D Hicks, P Owens, A Williams, DB Vaught, ... The Journal of clinical investigation 124 (11), 4737-4752, 2014 | 139 | 2014 |
| Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance? MM Williams, RS Cook Oncotarget 6 (6), 3519, 2015 | 135 | 2015 |
| Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers M Morrison Joly, DJ Hicks, B Jones, V Sanchez, MV Estrada, C Young, ... Cancer research 76 (16), 4752-4764, 2016 | 106 | 2016 |
| Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis M Morrison Joly, MM Williams, DJ Hicks, B Jones, V Sanchez, CD Young, ... Breast Cancer Research 19, 1-15, 2017 | 76 | 2017 |
| ErbB3 downregulation enhances luminal breast tumor response to antiestrogens MM Morrison, K Hutchinson, MM Williams, JC Stanford, JM Balko, ... The Journal of clinical investigation 123 (10), 4329-4343, 2013 | 69 | 2013 |
| Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression TJ Rogers, JL Christenson, LI Greene, KI O'Neill, MM Williams, ... Molecular Cancer Research 17 (1), 30-41, 2019 | 59 | 2019 |
| An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition CH Williams, JE Hempel, J Hao, AY Frist, MM Williams, JT Fleming, ... Cell reports 11 (1), 43-50, 2015 | 51 | 2015 |
| Key survival factor, Mcl-1, correlates with sensitivity to combined Bcl-2/Bcl-xL blockade MM Williams, L Lee, DJ Hicks, MM Joly, D Elion, B Rahman, C McKernan, ... Molecular Cancer Research 15 (3), 259-268, 2017 | 50 | 2017 |
| Estrogen receptor alpha mutations in breast cancer cells cause gene expression changes through constant activity and secondary effects S Arnesen, Z Blanchard, MM Williams, KC Berrett, Z Li, S Oesterreich, ... Cancer research 81 (3), 539-551, 2021 | 43 | 2021 |
| Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer MM Williams, NS Spoelstra, S Arnesen, KI O'Neill, JL Christenson, ... Cancer Research 81 (3), 732-746, 2021 | 35 | 2021 |
| ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation MM Williams, DB Vaught, MM Joly, DJ Hicks, V Sanchez, P Owens, ... Breast Cancer Research 19, 1-14, 2017 | 31 | 2017 |
| Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers MM Williams, L Lee, T Werfel, MMM Joly, DJ Hicks, B Rahman, D Elion, ... Cell Death & Disease 9 (2), 21, 2018 | 27 | 2018 |
| A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells AM Porman, JT Roberts, ED Duncan, ML Chrupcala, AA Levine, ... PLoS biology 20 (11), e3001885, 2022 | 26 | 2022 |
| Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer JL Christenson, KI O'Neill, MM Williams, NS Spoelstra, KL Jones, ... Molecular Cancer Therapeutics 20 (6), 1062-1071, 2021 | 25 | 2021 |
| Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth MM Morrison, MM Williams, DB Vaught, D Hicks, J Lim, C McKernan, ... Oncogene 35 (9), 1143-1152, 2016 | 24 | 2016 |
| MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer MM Williams, JL Christenson, KI O’Neill, SA Hafeez, CL Ihle, ... NPJ Breast Cancer 7 (1), 64, 2021 | 23 | 2021 |
| Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers MM Williams, DL Elion, B Rahman, DJ Hicks, V Sanchez, RS Cook Oncotarget 10 (52), 5389, 2019 | 23 | 2019 |
| A positive feedback loop between TGFβ and androgen receptor supports triple-negative breast cancer anoikis resistance E Rosas, JT Roberts, KI O’Neill, JL Christenson, MM Williams, ... Endocrinology 162 (2), bqaa226, 2021 | 13 | 2021 |
| Secreted indicators of androgen receptor activity in breast cancer pre-clinical models T Hanamura, JL Christenson, KI O’Neill, E Rosas, NS Spoelstra, ... Breast Cancer Research 23, 1-15, 2021 | 12 | 2021 |
| NPC1 confers metabolic flexibility in Triple Negative Breast Cancer KI O’Neill, LW Kuo, MM Williams, H Lind, LS Crump, NG Hammond, ... Cancers 14 (14), 3543, 2022 | 10 | 2022 |
Rebecca S. CookAssociate Professor of Biomedical Engineering, Vanderbilt University在 vanderbilt.edu 的电子邮件经过验证
